Search

everythinglearnresearchcommunity

for

Search:↓

Removing the ovaries can help treat hair loss caused by high androgen levels in postmenopausal women.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.